Mills-Peninsula Introduces New Treatment for Advanced Prostate Cancer
A new treatment that effectively targets cancer cells is offering pain relief, improved quality-of-life and extended survival time for men with late-stage prostate cancer that has spread to the bones.
Mills-Peninsula’s Dorothy E. Schneider Cancer Center has introduced this new cancer treatment, Xofigo (Radium-223 dichloride), for patients with advanced-stage prostate cancer that has metastasized to the bones, but not other organs. Xofigo was approved by the U.S. Food and Drug Administration (FDA) in May 2013 for treatment of metastatic castration-resistant prostate cancer. Mills-Peninsula’s cancer center is among the first in the Bay Area to offer this new treatment.
“This drug has very low toxicity and has the potential to create comfort in men who are suffering, and it may even prolong their lives,” says Stephen Weller, M.D., a Mills-Peninsula radiation oncologist. “It is an important drug — similar to other types of radiation treatment but more effective.”
Xofigo uses radiation to target cancer cells in bone tissue, while causing less damage to surrounding tissue than other types of radiation treatment. Its ability to chemically mimic calcium makes it especially effective in bone tissue.
“It is encouraging to offer treatment to men with painful bone metastases who are not responding to other therapies.”
Prostate cancer is the most common type of cancer in the United States, and the second most common cause of cancer death in men. The New England Journal of Medicine published results of a study in July 2013 showing Xofigo significantly improved overall survival rates in men with advanced prostate cancer.
About Mills-Peninsula’s Dorothy E. Schneider Cancer Center
Dorothy E. Schneider Cancer Center in San Mateo, Calif., offers the most advanced radiation oncology, infusion, counseling and care management services. The expert medical team provides treatment that exceeds national benchmarks on a variety of quality measures and embraces a vision of mind, body and spirit care that is equally important to healing. For more information about our Cancer Center’s treatment and care, visit mills-peninsula.org/cancer or call 650-696-4509.
If you liked this article, you may also like:
Mills-Peninsula Announces New Treatment for Peripheral Artery Disease Kimberly Dalal, M.D., Elected to Commission on Cancer Dr. Klonoff Inducted as Fellow of Royal College of Physicians of Edinburgh Bay Area Parent Names Mills Best Hospital & Birth Center on Peninsula U.S. News & World Report Names Mills Among Best California Hospitals